AzTrials
AzTrials

Osteo Arthritis of the KneeNCT07130552

Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty

A study testing femoral triangle block and popliteal plexus block and Femoral triangle block and distal iPACK in people with Osteo Arthritis of the Knee, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the effect of femoral triangle block combined with popliteal plexus block and distal IPACK block on postoperative pain after total knee arthroplasty (TKA) Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Osteo Arthritis of the Knee
What is being tested?
femoral triangle block and popliteal plexus block and Femoral triangle block and distal iPACK
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Dec 2025to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing total knee arthroplasty under spinal anesthesia
  • American Society of Anesthesiologists (ASA) status I-III
  • Patients who give informed consent

Who cannot join

  • Patients unable to cooperate
  • Kidney disease with GFR < 50 ml/min
  • Daily opioid consumption > 1 month
  • Allergy to local anesthetics
  • Neurological problems of the lower extremity
  • Contraindications to peripheral nerve blocks

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Karaman Training and Research Hospital, Karaman, Karaman 70200

    Karaman, 70200

    Tayfun Et, 05063670717, drtayfunet@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

This study aims to investigate the effect of femoral triangle block combined with popliteal plexus block and distal IPACK block on postoperative pain after total knee arthroplasty (TKA)

Read the detailed description

Popliteal Plexus Block (PPB) is a new nerve block technique that has been shown to anaesthetise nerves involved in the innervation of the posterior part of the knee joint.

The IPACK (interspace between the popliteal artery and capsule of the posterior knee) block is a regional anesthesia technique in which a local anesthetic is infiltrated under ultrasound guidance between the popliteal artery and the capsule of the posterior knee. This technique blocks the branches of the obturator nerve, the common peroneal nerve, and the tibial nerve in the popliteal region. In the context of knee arthroplasty, the application of the IPACK block has been associated with lower scores for ambulatory pain, lower scores for resting pain, and reduced morphine consumption.

Although both techniques of blockade seem to be efficient in the context of analgesia for the posterior part of the knee after TKA. No study compares these two blocks as part of multimodal analgesia to provide pain relief after TKA.

This study aimed to evaluate the analgesic effect of PPB or distal IPACK, in addition to femoral triangle block, as a component of a multimodal analgesic regimen after TKA.

Being tested
femoral triangle block and popliteal plexus block, Femoral triangle block and distal iPACK
Keywords
Total knee arthroplasty, popliteal plexus block, femoral triangle block, iPACK block (infiltration of the interspace between the popliteal artery and the posterior knee capsule)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • femoral triangle block and popliteal plexus blockDevice

    Single dose bolus, 10 ml 5% bupivacaine will be used for FTB, 10 ml 5% bupivacaine will be used for PPB

  • Femoral triangle block and distal iPACKDevice

    Single dose bolus, 10 ml 5% bupivacaine will be used for FTB, 10 ml 5% bupivacaine will be used for distal iPACK

Study groups in NCT07130552
Study groupRoleWhat they receive
Group Popliteal plexus blockExperimentalfemoral triangle block and popliteal plexus block
Receives: Device: femoral triangle block and popliteal plexus block
Group distal iPACKExperimentalFemoral triangle block and distal iPACK
Receives: Device: Femoral triangle block and distal iPACK

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Opioid consumption

    Total opioid consumption in each group, A, B until 24 hours postoperative.

    Measured: 24 hours

Secondary outcomes (11)
  1. NRS scores

    Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)

    Measured: 48 hours

  2. Range of knee motion

    Degrees of flexion

    Measured: 48 hours

  3. Patient mobilization

    Patient reporting time of first standing to the side of the bed and time up and go test 2 days

    Measured: 48 hours

  4. Post-block Maximum Voluntary Isometric Contraction (MVIC) by knee extension, calculated as a percentage of the Pre-block baseline value

    Both MVIC test are assessed preoperative, using a handheld dynamometer

    Measured: A 60-minute interval is between pre-block and post-block MVIC assessments

  5. Post-block MVIC by ankle plantarflexion, calculated as a percentage of the Pre-block baseline value

    Both MVIC tests are assessed preoperative, using a handheld dynamometer

    Measured: A 60-minute interval is between pre-block and post-block MVIC assessments

  6. Post-block MVIC by ankle dorsiflexion, calculated as a percentage of the Pre-block baseline value

    Both MVIC tests are assessed preoperative, using a handheld dynamometer

    Measured: A 60 minutes interval is between pre-block and post-block MVIC assessments

  7. Muscle strength of knee extension, graded by Manual Muscle Test (MMT)

    Grade 3: Able to extend the knee in active Range of Motion (ROM) against gravity, Grade 2: Patient is lying on the side, with knee resting on the bed, able to extend the knee in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the quadriceps muscle is palpable or observable but the knee does not extend, Grade 0: No muscle contraction of the quadriceps muscle is palpable or observable

    Measured: Assessed pre-block, post-block (60 minutes after pre-block), and postoperative 5 hours

  8. Muscle strength of ankle plantarflexion, graded by MMT

    Grade 3: Able to plantarflex in active ROM, Grade 2: Patient is lying on the side, with ankle resting on the bed, able to plantarflex the ankle in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the gastrocnemius muscle is palpable or observable but the ankle does not plantarflex, Grade 0: No muscle contraction of the gastrocnemius muscle is palpable or observable

    Measured: Assessed pre-block, post-block (60 minutes after pre-block) and postoperative 5 hours

  9. Muscle strength of ankle dorsiflexion, graded by MMT

    Grade 3: Able to dorsiflex in active ROM Grade 2: Patient is lying on the side, with ankle resting on the bed, able to dorsiflex the ankle in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the tibialis anterior muscle is palpable or observable but the ankle does not dorsiflex, Grade 0: No muscle contraction of the tibialis anterior muscle is palpable or observable

    Measured: Assessed pre-block, post-block (60 minutes after pre-block) and postoperative 5 hours

  10. Incidence of rebound pain

    Rebound pain is described as severe pain (NRS ≥ 7)

    Measured: Postoperative 24 hours

  11. Quality of Recovery 15 Score

    Quality of Recovery (QoR)-15 survey.Minimum value: 0, Maximum value: 150, higher scores mean better.

    Measured: Postoperative Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2025
  2. Study start29 Dec 2025
  3. Primary completion25 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07130552
Sponsor's protocol ID
06-2022/16
Status last verified
Sep 2026
First submitted
12 Aug 2025
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing femoral triangle block and popliteal plexus block and Femoral triangle block and distal iPACK in people with Osteo Arthritis of the Knee, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tayfun Et (+905063670717, drtayfunet@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Opioid consumption (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in